Viewing Study NCT03515005


Ignite Creation Date: 2025-12-25 @ 3:22 AM
Ignite Modification Date: 2025-12-26 @ 2:01 AM
Study NCT ID: NCT03515005
Status: TERMINATED
Last Update Posted: 2021-04-14
First Post: 2018-03-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Using Lay Health Advisors to Improve Hypertension Management
Sponsor: MetroHealth Medical Center
Organization:

Study Overview

Official Title: Using Lay Health Advisors to Help African Americans Address the Social Context of Hypertension Management
Status: TERMINATED
Status Verified Date: 2021-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Enrollment target not reached
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Hypertension disproportionately affects and is inadequately controlled among African American and poor populations. The investigators propose to determine the impact of using trained lay health advisors to help patients address social contextual factors that influence the management of hypertension.
Detailed Description: Hypertension disproportionately affects and is inadequately controlled among African American and poor populations. Health providers generally lack the skills and resources to address social contextual factors (i.e. health and community services, social networks, social stressors, physical environment, and economic resources) that influence management of hypertension. Instead, providers tend to focus on adjusting antihypertensive medication prescriptions and exhorting patients to exercise and eat better. The investigators propose to determine the impact of using trained lay health advisors to help patients address social contextual factors that influence the management of hypertension. Helping patients address these barriers may lead not only to improved blood pressure but also to increased survival, reduced organ damage, and decreased health care costs. This project may also serve as a model of healthcare delivery innovation that could be used to address other health disparity conditions.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: